These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9544298)

  • 21. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.
    Mitrakou A; Kelley D; Mokan M; Veneman T; Pangburn T; Reilly J; Gerich J
    N Engl J Med; 1992 Jan; 326(1):22-9. PubMed ID: 1727062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The possible mechanisms by which phanoside stimulates insulin secretion from rat islets.
    Hoa NK; Norberg A; Sillard R; Van Phan D; Thuan ND; Dzung DT; Jörnvall H; Ostenson CG
    J Endocrinol; 2007 Feb; 192(2):389-94. PubMed ID: 17283239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets.
    Björklund A; Grill V
    Diabetes; 1999 Jul; 48(7):1409-14. PubMed ID: 10389846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous insulin treatment in the Chinese hamster. A review.
    Grodsky GM
    Adv Exp Med Biol; 1988; 246():329-32. PubMed ID: 3074662
    [No Abstract]   [Full Text] [Related]  

  • 25. Diazoxide attenuates glucose-induced defects in first-phase insulin release and pulsatile insulin secretion in human islets.
    Song SH; Rhodes CJ; Veldhuis JD; Butler PC
    Endocrinology; 2003 Aug; 144(8):3399-405. PubMed ID: 12865318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Offspring of two diabetic parents: differential serum insulin responses to intravenous glucose and tolbutamide.
    Rojas L; Soeldner JS; Gleason RE; Kahn CB; Marble A
    J Clin Endocrinol Metab; 1969 Dec; 29(12):1569-79. PubMed ID: 4899852
    [No Abstract]   [Full Text] [Related]  

  • 27. Diazoxide and D600 inhibition of insulin release. Distinct mechanisms explain the specificity for different stimuli.
    Henquin JC; Charles S; Nenquin M; Mathot F; Tamagawa T
    Diabetes; 1982 Sep; 31(9):776-83. PubMed ID: 6131003
    [No Abstract]   [Full Text] [Related]  

  • 28. Diazoxide unmasks glucose inhibition of insulin release by counteracting entry of Ca2+.
    Bergsten P; Gylfe E; Wesslén N; Hellman B
    Am J Physiol; 1988 Oct; 255(4 Pt 1):E422-7. PubMed ID: 3052102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired glucose-induced insulin secretion: studies in animal models with spontaneous NIDDM.
    Ostenson CG; Khan A; Efendic S
    Adv Exp Med Biol; 1993; 334():1-11. PubMed ID: 8249675
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of alogliptin and pioglitazone on lipid metabolism in islets of prediabetic and diabetic Zucker Diabetic Fatty rats.
    Cai Y; Lydic TA; Turkette T; Reid GE; Olson LK
    Biochem Pharmacol; 2015 May; 95(1):46-57. PubMed ID: 25801003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B-cell insensitivity in vitro: reversal by diazoxide entails more than one event in stimulus-secretion coupling.
    Björklund A; Grill V
    Endocrinology; 1993 Mar; 132(3):1319-28. PubMed ID: 7679978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased sensitivity of the pancreatic beta cells to glucose in prediabetic and diabetic subjects. A glucose dose-response study.
    Cerasi E; Luft R; Efendic S
    Diabetes; 1972 Apr; 21(4):224-34. PubMed ID: 4552828
    [No Abstract]   [Full Text] [Related]  

  • 33. A unifying hypothesis for hereditary and acquired diabetes.
    Vinik AI; Kalk WJ; Jackson WP
    Lancet; 1974 Mar; 1(7856):485-7. PubMed ID: 4131886
    [No Abstract]   [Full Text] [Related]  

  • 34. Reduced dihydroxyacetone sensitivity and normal sensitivity to glyceraldehyde and oxidizing agent of ATP-sensitive K+ channels of pancreatic beta cells in NIDDM rats.
    Song DK; Park WK; Bae JH; Park MK; Kim SJ; Ho WK; Earm YE
    J Korean Med Sci; 1997 Aug; 12(4):286-92. PubMed ID: 9288626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta cells and glucose in diabetes.
    Nutr Rev; 1973 Jan; 31(1):8-10. PubMed ID: 4571257
    [No Abstract]   [Full Text] [Related]  

  • 36. Beta-cell behaviour during the prediabetic stage. Part II. Non-insulin-dependent and insulin-dependent diabetes mellitus.
    Homo-Delarche F
    Diabetes Metab; 1997 Dec; 23(6):473-505. PubMed ID: 9496555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormalities of insulin responses after ambient and previous exposure to glucose in streptozocin-diabetic and dexamethasone-treated rats. Role of hyperglycemia and increased B-cell demands.
    Grill V; Rundfeldt M
    Diabetes; 1986 Jan; 35(1):44-51. PubMed ID: 2416619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recovery of glucose-induced insulin secretion in a rat model of NIDDM is not accompanied by return of the B-cell GLUT2 glucose transporter.
    Chen C; Thorens B; Bonner-Weir S; Weir GC; Leahy JL
    Diabetes; 1992 Oct; 41(10):1320-7. PubMed ID: 1397706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NIDDM is associated with loss of pancreatic beta-cell L-type Ca2+ channel activity.
    Roe MW; Worley JF; Tokuyama Y; Philipson LH; Sturis J; Tang J; Dukes ID; Bell GI; Polonsky KS
    Am J Physiol; 1996 Jan; 270(1 Pt 1):E133-40. PubMed ID: 8772485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose intolerance in young TallyHo mice is induced by leptin-mediated inhibition of insulin secretion.
    Sung YY; Lee YS; Jung WH; Kim HY; Cheon HG; Yang SD; Rhee SD
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1779-87. PubMed ID: 16288988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.